InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCoV-2 Ag Detect Rapid Test. SEATTLE, Sept. 5, 2024 /PRNewswire-PRWeb/ — With a…
InBios Receives FDA 510(k) Clearance for COVID-19 POC Antigen Detection Test
This post was originally published on this site